The Pentagon has spent decades refining how it tests, trains, and equips its warfighters. It has standards for eyesight, body fat, hearing, fitness, and dental health. Now Defense Secretary Pete Hegseth is adding something new to that list: a blood test for testosterone.
The U.S. military will begin testing the testosterone levels of some service members and recommending hormone therapy if needed, Hegseth announced on Wednesday. He posted a video to X captioned “The High-T Department of War,” saying that warfighters age 30 and older will be tested annually as part of their periodic health assessment. The announcement landed somewhere between a genuine public health initiative and a culture-war statement, and medical experts aren’t entirely sure which one it is.
The policy raises real questions that haven’t been answered yet: what counts as a deficiency, what happens to troops who fall short, and whether the science backs a program of this scale.
What the Policy Actually Says
The Pentagon will begin annually screening service members for testosterone deficiency. Under the new program, service members aged 30 and older will be tested yearly as part of routine health assessments, while troops under 30 will have the option to be tested.
The decision to receive testosterone replacement therapy (TRT), if recommended by a medical professional, will remain up to the individual service member. Hegseth was careful to frame the treatment as optional, and he was equally careful about how he defined the program’s purpose. “This initiative, it’s not about artificial enhancement; it’s about restoring and optimizing your natural capabilities, protecting your longevity, and ensuring you have the biological foundation required to sustain the fight,” he said.
He framed the annual screening as part of an investment in “the individual warfighter,” calling service members “our most decisive tactical advantage” and arguing it was a “sacred duty” to maintain that advantage. Hegseth said the military “invests heavily in weapon systems, platforms and gear,” but that its most decisive tactical advantage will always be the individual warfighter.
Service members have long had access to testosterone testing and replacement therapy through Tricare, the health insurance program for military personnel and their families. But screenings have never been part of the military’s annual health assessments, which have traditionally focused on vaccinations, vision and hearing tests, and other routine medical evaluations. Testosterone screening is not a new treatment being introduced. It’s a new requirement that puts hormone levels on the same footing as blood pressure and hearing, items that can affect a service member’s medical readiness profile.
The Medical Case For It
Roughly 5.6 percent of men between 30 and 79 have symptomatic testosterone deficiency, which can cause muscle loss, fatigue, weight gain, and sexual dysfunction. It is also linked to other serious health conditions including diabetes, cardiovascular disease, osteoporosis, and depression.
The hormone does decline with age. According to the Mayo Clinic, testosterone levels gradually decline at roughly 1% a year after age 30 or 40. That’s a slow drip over time, not a cliff edge, but for someone in a physically demanding profession, that compounding loss can have real consequences. Fatigue, reduced muscle mass, mood changes, and disrupted sleep are all documented effects of genuinely low testosterone. For a soldier required to operate under chronic physical and psychological stress, those symptoms aren’t abstract.
A number of special operations veterans have established nonprofits and non-traditional treatment plans to help former service members who deal with physical and mental health issues linked to low testosterone levels, including sleep disruptions, emotional numbing, and loss of motivation. The term “Operator Syndrome” describes a broader cluster of health issues that special operators develop from years of extreme physical stress, including traumatic brain injury effects, hormonal disruption, and low testosterone as one documented component.
The issue attracted attention from lawmakers in 2024 when a measure was included in the fiscal year 2025 national defense bill asking the Secretary of Defense to brief members of Congress on the military’s available treatments for low testosterone and current protocols for testing and screening. So this isn’t a policy that materialized out of nowhere. It has been building for a couple of years, with legitimate clinical concern underneath it.
Whether a blanket testosterone screening program for all troops over 30 is the right instrument for that concern is a different question entirely.
Where the Science Gets Complicated
Medical experts who treat men for low testosterone point out a problem at the center of this policy: testing testosterone is harder than it sounds, and the results can be misleading in exactly the environment where soldiers operate.
Sleep deprivation, intense physical training, weight changes, illness, and certain medications can all temporarily lower testosterone levels. Doctors should evaluate those factors before determining that a service member has a testosterone deficiency. A soldier coming off a hard training cycle, running on poor sleep, under significant stress, which describes most service members much of the time, is likely to test lower than their baseline. Acting on that single reading with a hormone prescription would be, at a minimum, premature.
Typically, doctors are advised to discuss testosterone therapy with men who have troubling symptoms and documented low levels of the hormone on two separate blood tests. Testing for testosterone is challenging because levels of the hormone fluctuate throughout the day, and accurate readings are typically measured in the morning after fasting. A once-a-year snapshot during an annual health assessment may not capture a meaningful picture at all.
The American Urological Association told ABC News that a testosterone deficiency diagnosis requires both symptoms and signs of low testosterone along with at least two separate early-morning total testosterone measurements demonstrating low levels. Meanwhile, up to a third of men who are put on testosterone therapy in general practice do not meet the criteria for a medical diagnosis. That figure comes from civilian medicine, where TRT prescriptions have grown substantially in recent years, some of it appropriate, some of it not. The military’s program will need to be more rigorous than the average men’s health clinic if it wants to avoid repeating that pattern at scale.
Also unaddressed is how the military will square a program that screens troops for low testosterone with the FDA’s stance that testosterone replacement therapy is approved only for men with a diagnosed medical condition affecting hormone production. The U.S. Food and Drug Administration does not approve testosterone replacement therapy for males without specific forms of hypogonadism, a medical condition associated with a malfunction of the organs that produce testosterone.
The Broader Context: A Policy Pattern
According to NBC News, the testosterone screening requirement is the latest policy shift under Hegseth, an Army National Guard veteran and former Fox News co-host, whose tenure at the Pentagon has included a series of moves to reshape the force around physical standards and what he describes as a warrior ethos. In a speech to senior officers at Marine Corps Base Quantico, he declared there would be “no more beardos” and no more “fat troops,” unveiling a slate of directives on fitness and appearance.
The new policy comes amid a larger push by the Trump administration to promote and expand public access to testosterone replacement therapies. Health Secretary Robert F. Kennedy Jr. and other Trump administration officials are moving to make it easier for doctors to prescribe testosterone. Last month, the Food and Drug Administration proposed easing prescribing limits on testosterone gels, pills, patches, and injections.
The political dimension has not been lost on lawmakers. Senator Tammy Duckworth, an Illinois Democrat and Iraq War veteran, said the announcement sounded “like gender-affirming care to me,” referencing Hegseth’s stance against transgender troops. Representative Chrissy Houlahan, a Pennsylvania Democrat and Air Force veteran, said the announcement “proves that Secretary Hegseth takes direction from the far corners of the manosphere,” and both lawmakers called on Hegseth to make hormone testing available for both men and women.
The Pentagon has not answered whether there would be estrogen screenings for female service members, or whether there would be repercussions for service members who declined the recommended testosterone treatment, instead referring reporters to Hegseth’s video. Both questions matter. Women serve in the military. They age. Their hormones shift too. The silence on that front is conspicuous.
It is also unclear what testosterone levels the Pentagon would find acceptable, and whether troops with lower levels could face professional consequences. The military already uses medical standards that can affect a service member’s ability to deploy. Troops with unresolved dental issues, for example, can be deemed non-deployable, a designation that can limit assignments and, over time, have significant career consequences. If hormone levels eventually become part of deployability assessments, even informally, the “voluntary” framing of TRT starts to look complicated.
What to Make of All This
Special operations communities have dealt with the downstream health effects of extreme physical stress for years, and low testosterone is a documented part of that picture. “High-T Department of War” is not a clinical framing. It’s a culture-war slogan attached to a health policy, and the combination is worth scrutinizing. When the Pentagon declines to explain what evidence base underlies the program, what thresholds will define deficiency, what happens to a troop who tests low and declines treatment, and whether female service members will receive equivalent hormonal attention, those aren’t minor administrative details. They are the policy.
The medical community’s caution on blanket testosterone screening isn’t obstruction. It reflects hard-won knowledge about how easy it is to overdiagnose, overtreat, and expose patients, including young men who want to be fertile someday, to interventions they didn’t need. TRT can impair sperm production and fertility, particularly in younger men. A 22-year-old soldier who tests slightly low after two weeks of sleep deprivation and field rations probably doesn’t need hormone therapy. He needs a decent meal and eight hours of sleep. The challenge for military doctors implementing this program will be holding that line when the policy pressure runs in the other direction.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.